Allocrypt aims to provide a missing element in the new generation of medical diagnostic devices by ensuring secure (authenticated, private, integrity protected) test results directly from devices to doctors. Allocrypt will integrate with existing health information systems, comply with HIPAA and FDA Part 11. Allocrypt will operate the required security infrastructure. Patient outcomes will improve, costs will decrease, Allocrypt's revenue will come from infrastructure. The infrastructure design is general and adaptable; other applications that don't require FDA certification will provide early cash flow.